FIELD: medicine.
SUBSTANCE: method includes application of individually chosen hypohigh-calorie diet, the dosed out physical activities and introduction of Pyoglitazone 30 mg once a day and Valsartane 80 mg, 1 time at the same time of the day. The combined application of a hypohigh-calorie diet, physical activities and Pyoglitazone and Valsartane preparations in the specified dosages allows normalising activity of protein C within three months at patients with metabolic syndrome.
EFFECT: optimisation of activity of protein C at patients with metabolic syndrome.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF THROMBIN TIME NORMALISATION FOR METABOLIC SYNDROME | 2007 |
|
RU2349318C1 |
METHOD OF QUICK ENDOTHELIOCYTEMIA NORMALISATION ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2345767C1 |
METHOD OF α ANTIPLASMIN LEVEL NORMALISATION UNDER METABOLIC SYNDROME | 2007 |
|
RU2344818C1 |
METHOD OF THROMBOPLASTIN FORMATION FOR PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2332205C1 |
METHOD OF NORMALISATION OF THROMBOCYTE SUSCEPTIBILITY TO AGGREGATION STIMULATION AGENTS FOR ARTERIAL HYPERTENSION PATIENTS UNDER METABOLIC SYNDROME | 2007 |
|
RU2344815C1 |
METHOD FOR NORMALISATION OF ADENOSINE DIPHOSPHATE AND ADENOSINE TRIPHOSPHATE SECRETION BY PLATELETS IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2344855C1 |
METHOD OF THROMBOPLASTIN FORMATION NORMALISATION IN PATIENTS SUFFERING FROM METABOLIC SYNDROME | 2007 |
|
RU2345771C1 |
METHOD FOR ENHANCEMENT OF THROMBOCYTE ANTIOXIDANT PROOFNESS IN ARTERIAL HYPERTENSION CASES WITH METABOLIC SYNDROME | 2007 |
|
RU2331416C1 |
METHOD OF FIBRINOSIS LEVEL OPTIMISATION AT METABOLIC SYNDROME | 2007 |
|
RU2342933C1 |
NORMALISATION METHOD OF LIPID CONTENT IN THROMBOCYTE MEMBRANES ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2345766C1 |
Authors
Dates
2009-01-10—Published
2007-06-19—Filed